Table 2.
Recipient characteristics of preemptive compared with non-preemptive living donor kidney transplant recipients.
| LDKT recipient characteristics | Preemptive n=14,503 |
Dialysis < 1yr n=7,590 |
Dialysis ≥ 1yr n=17,503 |
p-value |
|---|---|---|---|---|
| Age (years: mean ± SD) | 47 (±15) | 43 (±16) | 46 (± 15) | <0.01 |
| Gender (% female) | 41% (5,937) | 37% (2,819) | 39% (6,761) | <0.01 |
| Race/Ethnicity: White | 77% (11,130) | 67% (5,102) | 52% (9,151) | <0.01 |
| African-American | 9% (1,340) | 12% (903) | 21% (3,655) | |
| Hispanic/Latino | 9% (1,384) | 15% (1,152) | 20% (3,518) | |
| Other/missing | 4% (649) | 6% (433) | 7% (1,179) | |
| Sensitization: cPRA <20% | 50% (7,185) | 44% (3,302) | 42% (7,282) | <0.01 |
| cPRA 20-79% | 6% (858) | 5% (378) | 11% (1,186) | |
| cPRA ≥80% | 1% (202) | 2% (124) | 3% (588) | |
| missing* | 43% (6,258) | 50% (3,786) | 48% (8,447) | |
| Blood type: O | 43% (6,188) | 44% (3,342) | 47% (8,271) | <0.01 |
| A | 40% (5,865) | 40% (2,995) | 35% (6,088) | |
| B | 13% (1,826) | 12% (943) | 15% (2,555) | |
| AB | 4% (624) | 4% (310) | 3% (589) | |
| Diagnosis: Diabetes | 16% (2,289) | 22% (1,651) | 24% (4,203) | <0.01 |
| Hypertension | 13% (1,939) | 16% (1,185) | 22% (3,839) | |
| PCKD | 19% (2,701) | 7% (536) | 5% (944) | |
| Glomerulonephritis | 28% (4,111) | 31% (2,383) | 27% (4,772) | |
| Other/missing | 24% (3,463) | 24% (1,835) | 21% (3,745) | |
| Pediatric patient (age<18) | 4% (576) | 4% (333) | 2% (401) | <0.01 |
| Payer/insurance: Private | 76% (11,003) | 64% (4,809) | 38% (6,688) | <0.01 |
| Medicare | 18% (2,673) | 31% (2,348) | 56% (9,721) | |
| Other/missing | 6% (827) | 6% (433) | 6% (1,094) | |
| Prior transplant | 8% (1,211) | 10% (790) | 10% (1,744) | <0.01 |
*
Mandatory reporting of cPRA was not instituted until 2007, and thus only available on patients listed from 2007-2012.